Aspartyl proteinases of Candida albicans and their role in pathogenicity

By Bernardis F. de   Sullivan P. A.   Cassone A.  

Medical Mycology, Vol. 39, Iss. 4, 2001-08 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite

In vitro pro- and anti-inflammatory responses to viable Candida albicans yeasts by a murine macrophage cell line

By Sarazin Aurore   Poulain Daniel   Jouault Thierry  

Medical Mycology, Vol. 48, Iss. 7, 2010-11 ,pp. : 912-921

Informa Healthcare

Access to resources Recommend Favorite

Fluconazole therapy of oropharyngeal candidiasis in a patient with multiple endocrine failure does not correlate with Candida albicans susceptibility to fluconazole in vitro

By Field E.A.   Millns B.   Pearce P.K.   Martin M.V.   Parkinson T.   Hitchcock C.A.  

Medical Mycology, Vol. 34, Iss. 3, 1996-06 ,pp. : 205-208

Informa Healthcare

Access to resources Recommend Favorite

The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans

By Kim Narae   Kim Jeong-Keun   Hwang Dahyun   Lim Young-Hee  

Medical Mycology, Vol. 51, Iss. 1, 2013-01 ,pp. : 45-52

Informa Healthcare

Access to resources Recommend Favorite

Candida albicans: adherence, signaling and virulence

By Calderone R.   Suzuki S.   Cannon R.   Cho T.   Boyd D.   Calera J.   Chibana H.   Herman D.   Holmes A.   Jeng H-W.   Kaminishi H.   Matsumoto T.   Mikami T.   O'Sullivan J. M.   Sudoh M.   Suzuki M.   Nakashima Y.   Tanaka T.   Tompkins G. R.   Watanabe T.  

Medical Mycology, Vol. 38, Iss. 1, 2000-12 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite